CERE 44.96 (+0%)
US15678U1280BiotechnologyBiotechnology

Cerevel Therapeutics Holdings (CERE) Stock Highlights

44.96 | +0%
2024-11-21 01:05:54
Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinsons disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Statistics

Range Today
44.96 44.96
Volume Today 0
Range 1 Year
19.59 44.99
Volume 1 Year 439.93M
Range 3 Year
19.59 46.16
Volume 3 Year 717.6M
Range 10 Year
9 46.16
Volume 10 Year 903.53M

Highlights

Market Capitalization 8.19B (mid)
Floating Shares 77.82M
Current Price 44.96
Price To Earnings -16.48
Price To Book 14.49
Earnings Per Share -2.73
Payout Ratio 0%

Performance

Latest 0%
1 Month +9.26%
3 Months +5.64%
6 Months +7.25%
1 Year +47.41%
3 Years +79.91%
5 Years +222.53%
10 Years +222.53%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.